Dafna Capital Management LLC Viking Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

$331 Million
Q1 2025

A detailed history of Dafna Capital Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 64,516 shares of VKTX stock, worth $1.73 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

64,516

Previous 64,516 -0.0%

Holding current value

$1.73 Million

Previous $2.6 Million 39.98%

% of portfolio

0.47%

Previous 0.71%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$38.28 - $78.03 $2.34 Million - $4.77 Million	-61,100 Reduced 48.64%	64,516 $2.6 Million
Q3 2024 Nov 14, 2024	SELL	$49.84 - $70.47 $3.16 Million - $4.47 Million	-63,501 Reduced 33.58%	125,616 $7.95 Million
Q2 2024 Aug 14, 2024	SELL	$47.39 - $80.2 $236,950 - $401,000	-5,000 Reduced 2.58%	189,117 $10 Million
Q1 2024 May 15, 2024	SELL	$17.4 - $94.5 $941,339 - $5.11 Million	-54,100 Reduced 21.8%	194,117 $15.9 Million
Q4 2023 Feb 14, 2024	SELL	$9.24 - $19.64 $660,087 - $1.4 Million	-71,438 Reduced 22.35%	248,217 $4.62 Million
Q3 2023 Nov 14, 2023	BUY	$10.92 - $16.0 $283,920 - $416,000	26,000 Added 8.85%	319,655 $3.54 Million
Q2 2023 Aug 14, 2023	SELL	$14.84 - $24.79 $378,420 - $632,145	-25,500 Reduced 7.99%	293,655 $4.76 Million
Q1 2023 May 15, 2023	SELL	$8.08 - $17.33 $1.64 Million - $3.51 Million	-202,398 Reduced 38.81%	319,155 $5.31 Million
Q4 2022 Feb 14, 2023	SELL	$2.72 - $9.4 $83,903 - $289,961	-30,847 Reduced 5.58%	521,553 $4.9 Million
Q3 2022 Nov 14, 2022	BUY	$2.55 - $3.89 $229,499 - $350,100	90,000 Added 19.46%	552,400 $1.5 Million
Q2 2022 Aug 15, 2022	BUY	$2.11 - $3.15 $31,649 - $47,250	15,000 Added 3.35%	462,400 $1.34 Million
Q1 2021 May 17, 2021	SELL	$5.74 - $9.67 $48,790 - $82,195	-8,500 Reduced 1.86%	447,400 $2.83 Million
Q4 2020 Feb 16, 2021	BUY	$5.3 - $6.71 $26,500 - $33,550	5,000 Added 1.11%	455,900 $2.57 Million
Q1 2020 May 15, 2020	BUY	$3.45 - $7.95 $833,865 - $1.92 Million	241,700 Added 115.54%	450,900 $2.11 Million
Q2 2019 Aug 14, 2019	BUY	$7.67 - $10.63 $230,100 - $318,900	30,000 Added 16.74%	209,200 $1.74 Million
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $1.28 Million - $2.9 Million	179,200 New	179,200 $1.37 Million

Others Institutions Holding VKTX

# of Institutions

432

Shares Held

65.2M

Call Options Held

8.28M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.05B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Viking Therapeutics, Inc. Transaction History